Baker Bros. Advisors LP Immunocore Holdings PLC Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Baker Bros. Advisors LP holds 2,322,656 shares of IMCR stock, worth $76.4 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
2,322,656
Previous 1,515,318
53.28%
Holding current value
$76.4 Million
Previous $44.7 Million
54.16%
% of portfolio
0.82%
Previous 0.5%
Shares
4 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$232 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$202 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$160 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$88.2 Million0.07% of portfolio
-
Tang Capital Management LLC San Diego, CA1.92MShares$63 Million3.69% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.44B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...